Neurology® Podcast Overview from the 2025 International Stroke Conference
Mar 3, 2025
Dr. Seemant Chaturvedi, a stroke neurology expert from the University of Maryland, shares cutting-edge insights from the International Stroke Conference. He discusses important advancements in stroke treatments, including the role of endovascular therapy and findings from trials such as ESCAPE-MeVO and PRESTIAGE-AF. Chaturvedi also explores the complexities of anticoagulant use post-brain hemorrhage and innovative approaches like transcranial direct current stimulation for recovery. His expert insights emphasize the ongoing evolution of stroke care and research.
AI Snips
Chapters
Transcript
Episode notes
EVT for Distal Occlusions
- Recent trials challenge the use of EVT for distal occlusions (MEVOs).
- Two trials, ESCAPE-MeVO and DISTAL, showed no clear benefit for MEVOs.
MEVO Thrombectomy Results
- Trials show no benefit for thrombectomy in medium vessel occlusions currently.
- Higher intracranial hemorrhage risk with thrombectomy in MEVOs.
Post-Thrombectomy TNK
- ANGEL-TNK trial suggests post-thrombectomy intra-arterial TNK may improve outcomes.
- Other trials have shown mixed results, so further analysis is needed.